Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Johnson and Johnson
UBS
Teva
Farmers Insurance
Argus Health
Express Scripts
Deloitte

Generated: July 21, 2018

DrugPatentWatch Database Preview

Hydrochlorothiazide; irbesartan - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; irbesartan and what is the scope of hydrochlorothiazide; irbesartan freedom to operate?

Hydrochlorothiazide; irbesartan
is the generic ingredient in two branded drugs marketed by Sanofi Aventis Us, Alembic Pharms Ltd, Apotex Inc, Atlas Pharms Llc, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Hisun Pharm Hangzhou, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Prinston Inc, Sandoz, Teva, Unichem Labs Ltd, Watson Labs Inc, and West-ward Pharms Int, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; irbesartan. Nineteen suppliers are listed for this compound. There are six tentative approvals for this compound.
Summary for hydrochlorothiazide; irbesartan
Pharmacology for hydrochlorothiazide; irbesartan
Synonyms for hydrochlorothiazide; irbesartan
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide, mixt. with 2-butyl-3-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1,3-diazaspiro(4.4)non-1-en-4-one
448264-66-2
C25H28N6O.C7H8ClN3O4S2
CoAprovel
DTXSID80196314
Hydrochlorothiazide / Irbesartan
Hydrochlorothiazide mixture with Irbesartan
Irbesartan Hydrochlorothiazide BMS
Irbesartan Hydrochlorothiazide Winthrop
Irbesartan-hydrochlorothiazide
Karvezide
LS-178480
SCHEMBL2527626
Tentative approvals for HYDROCHLOROTHIAZIDE; IRBESARTAN
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up12.5MG;150MGTABLET;ORAL
➤ Sign Up➤ Sign Up12.5MG;300MGTABLET;ORAL
➤ Sign Up➤ Sign Up25MG;300MGTABLET; ORAL

US Patents and Regulatory Information for hydrochlorothiazide; irbesartan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem Labs Ltd IRBESARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; irbesartan TABLET;ORAL 207018-001 Sep 19, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us AVALIDE hydrochlorothiazide; irbesartan TABLET;ORAL 020758-002 Sep 30, 1997 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hisun Pharm Hangzhou IRBESARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; irbesartan TABLET;ORAL 207896-001 Oct 14, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Unichem Labs Ltd IRBESARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; irbesartan TABLET;ORAL 207018-002 Sep 19, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for hydrochlorothiazide; irbesartan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us AVALIDE hydrochlorothiazide; irbesartan TABLET;ORAL 020758-003 Aug 31, 1998 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us AVALIDE hydrochlorothiazide; irbesartan TABLET;ORAL 020758-003 Aug 31, 1998 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us AVALIDE hydrochlorothiazide; irbesartan TABLET;ORAL 020758-001 Sep 30, 1997 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us AVALIDE hydrochlorothiazide; irbesartan TABLET;ORAL 020758-004 Mar 15, 2005 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Merck
Dow
Express Scripts
Cipla
Teva
Mallinckrodt
Johnson and Johnson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.